Fit Investment Ideas

I wrote here several times about NSKOG. I am long and I like the story. It is cheap vs peers and its green itiatives at valued at zero. Pareto analyst believes the green intiatives have value equal to its mkt cap. It is cheap. And it is very cheap when paper prices are raising asContinue reading “NorsKe Skog – cheap vs peers, renewables activities for free”

Friday was bloody. The markets are quite high and becomming fragile. I wrote here about many long ideas, that I played. I have been torturing myself how to hedge against violent downturn. I am looking at short ideas, that are short based on its fundamentals – that will go down it good or bad markets.Continue reading “Elegant way to protect Scandi portfolio against downturn”

Today Biovica International published its annual results. There are important quotes in the CEO comments that investors should focus on:  “We are following our schedule for being able to launch DiviTum®TKa in the USA during the third quarter 2021 and utilizing the time prior to approval in the best way possible.” “Our application is oneContinue reading “Biovica should double by the start of commercial launch in today confirmed Q3”

In mid April 2021 I wrote about XBrane for the first time. At that time Xbrane was trading around 78 SEK, it is 170 SEK today. The reason for the share price growth was the imminent announcement of Phase 3 results and very high likelihood of positive outcome (97% for biosimilars). These shares always perform well priorContinue reading “Biovica – FDA approval in Q3, commercionalisation in Q4”

On the Q1 presentation Quantafuel management stated, that they should have a continues production by the end of Q2. That is in two weeks or so. They said it only a month ago on 14/5/21. They gave themselves quite a short deadline, so they must have known they are very close. It would be irrationalContinue reading “Quantafuel trade for the next month – 100% upside vs 10% downside”

In mid April 2021 I wrote about XBrane for the first time. I recomended the investment based on the below thesis. At that time Xbrane was trading around 78 SEK. I sold again part of my holdings at 160 SEK. The idea generated more than 100% return over less than two months, which is over 600% annualised return.Continue reading “Xbrane up 100% in 3 months. Biovica will follow the lead.”

I have bought into two new transactions in the last two days: Noble and Valaris. These are rig owners that went through bankruptcy, got deleveraged and relisted. The companies are trading at significant discount to its peers, that have not deleveraged. Very interesting opportunity. I enclose summaries from research reports published yesterday on both. ItContinue reading “Noble and Valaris – restructured and deleveraged rig companies are back in the market at a discount to unrestructured peers”

I am long MPC Energy Solution. It is one of the investments, that seems to be right, but takes time to move. This morning SpareBank issued new research report – summary is below: MPC Energy Solutions | MPCES NO Priced at cash despite significant value potential in firm backlog This morning MPCES announced that itContinue reading “MPC Energy Solutions – Priced at cash despite significant value potential in firm backlog.”

In mid April 2021 I wrote about XBrane for the first time. I recomended the investment based on the below thesis. At that time Xbrane was trading around 78 SEK. I sold today part of my holdings at 145 SEK. The idea generated 85% return over less than two months, which is over 500% annualisedContinue reading “BIOVICA – Trade for the next quarter”

We have been very bullish on Norske Skog. Pareto and Sparebank has added today NSKOG to their top ideas: Pareto Securities today: Pareto Securities Top Ideas for Norway published today: Equity Portfolio Norway – May closed out Q1 reporting season and global equity markets were flattish with inflation in focus. Our portfolio returned 1.5% m/m,Continue reading “NSKOG – TOP IDEA at Pareto and Sparebank”